Wahed Invest LLC Exact Sciences Corp Transaction History

Wahed Invest LLC

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$41.33 - $74.26 $17,193 - $30,892	416 Added 12.03%	3,875 $163,000
Q1 2024 May 15, 2024	BUY	$56.27 - $73.77 $23,183 - $30,393	412 Added 13.52%	3,459 $238,000
Q4 2023 Mar 11, 2024	SELL	$59.06 - $75.72 $1.16 Million - $1.49 Million	-19,682 Reduced 86.59%	3,047 $225,000
Q4 2023 Feb 14, 2024	BUY	$59.06 - $75.72 $1.18 Million - $1.51 Million	19,909 Added 705.99%	22,729 $1.68 Million
Q3 2023 Nov 14, 2023	BUY	$65.94 - $99.04 $17,935 - $26,938	272 Added 10.68%	2,820 $192,000
Q2 2023 Aug 14, 2023	BUY	$62.68 - $95.05 $14,040 - $21,291	224 Added 9.64%	2,548 $239,000
Q1 2023 May 15, 2023	BUY	$47.19 - $70.77 $23,217 - $34,818	492 Added 26.86%	2,324 $157,000
Q4 2022 Feb 14, 2023	SELL	$30.35 - $53.15 $6,434 - $11,267	-212 Reduced 10.37%	1,832 $90,000
Q3 2022 Nov 14, 2022	BUY	$31.97 - $49.37 $5,626 - $8,689	176 Added 9.42%	2,044 $66,000
Q2 2022 Aug 15, 2022	BUY	$35.61 - $76.23 $66,519 - $142,397	1,868 New	1,868 $74,000
Q1 2022 May 16, 2022	SELL	$57.56 - $82.54 $124,790 - $178,946	-2,168 Closed	0 $0
Q4 2021 Feb 14, 2022	BUY	$72.5 - $100.68 $157,180 - $218,274	2,168 New	2,168 $169,000

673

162M

2.58M

2.19M

Ticker EXAS
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 176,960,000
Market Cap $10.2B
Description
Exact Sciences Corporation provides cancer screening and diagnostic test products in the United States and internationally. The company offers Cologuard, a non-invasive stool-based DNA screening test to detect DNA and hemoglobin biomarkers associated with colorectal cancer and pre-cancer. It also provides Oncotype DX, a gene expression tests for...

Get notified when there are updates to the investment portfolio of Wahed Invest LLC, based on Form 13F filings with the SEC.

Stay updated on Wahed Invest LLC with notifications on news.